2022
DOI: 10.1002/open.202200090
|View full text |Cite
|
Sign up to set email alerts
|

Affinity Chromatography‐Based Assays for the Screening of Potential Ligands Selective for G‐Quadruplex Structures

Abstract: DNA G‐quadruplexes (G4s) are key structures for the development of targeted anticancer therapies. In this context, ligands selectively interacting with G4s can represent valuable anticancer drugs. Aiming at speeding up the identification of G4‐targeting synthetic or natural compounds, we developed an affinity chromatography‐based assay, named G‐quadruplex on Oligo Affinity Support (G4‐OAS), by synthesizing G4‐forming sequences on commercially available polystyrene OAS. Then, due to unspecific binding of severa… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
6
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4
2

Relationship

2
4

Authors

Journals

citations
Cited by 10 publications
(9 citation statements)
references
References 80 publications
0
6
0
Order By: Relevance
“…The G4-CPG assay is an affinity chromatography-based method conceived to improve the previously developed G-quadruplex on Oligo Affinity Support (G4-OAS) [ 11 , 26 , 27 ], allowing for the rapid and easy selection of G-quadruplex-specific ligands. It involves flowing solutions of putative G-quadruplex ligands through a Controlled Pore Glass (CPG) support functionalized with G-quadruplex-forming oligonucleotides.…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations
“…The G4-CPG assay is an affinity chromatography-based method conceived to improve the previously developed G-quadruplex on Oligo Affinity Support (G4-OAS) [ 11 , 26 , 27 ], allowing for the rapid and easy selection of G-quadruplex-specific ligands. It involves flowing solutions of putative G-quadruplex ligands through a Controlled Pore Glass (CPG) support functionalized with G-quadruplex-forming oligonucleotides.…”
Section: Resultsmentioning
confidence: 99%
“…The compounds with high affinity for the G-quadruplex are retained, while those with low-to-null affinity are eluted. All the assay steps are monitored with UV measurements [ 10 , 11 ]. The two following cancer-related G-quadruplex-forming DNA sequences were chosen here as targets: (i) tel 26 , a 26-mer oligonucleotide of sequence d(TTAGGGTTAGGGTTAGGGTTAGGGTT), able to fold into a hybrid G-quadruplex, with its sequence extracted from the human 3′-telomeric overhang [ 28 ], and (ii) c-myc, a 33-mer oligonucleotide able to fold into a parallel G-quadruplex of sequence d(TGGGGAGGGTGGGGAGGGTGGGGAAGGTGGGGA), reproducing the regulatory region of the gene coding for the transcription factor C-MYC [ 29 ].…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…[19,20] While certain progress in the design of more specific G4 ligands has been achieved during the last years, [21] one of the obstacles is the lack of high-throughput technologies combining the synthesis and biochemical evaluation (profiling) of G4tagerted libraries of putative ligands. In this regard, emerging technologies such as G4-targeted fragment-based screening, [22,23] DNA-encoded chemical libraries, [24] affinity chromatography [25,26] and affinity-selection mass spectrometry, [27,28] or rapid synthesis and evaluation of G4 ligands on a microfluidic platform [29] represent promising alternatives to the classical, robust but time-consuming combinatorial chemistry approaches that rely on the preparative synthesis of putative ligands, followed by their biophysical or biochemical assessment on a one-by-one basis. [30][31][32] Within the chemical space of G4 ligands, quaternary heterocyclic bis(carboxamides) represent one of the oldest and most efficient families.…”
Section: Introductionmentioning
confidence: 99%